Literature DB >> 1353538

Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers.

D R Ciocca1, F K Fujimura, A K Tandon, G M Clark, C Mark, G J Lee-Chen, G W Pounds, P Vendely, M A Owens, M R Pandian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1353538     DOI： 10.1093/jnci/84.16.1279

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

2.  HER2 and β-catenin protein location: importance in the prognosis of breast cancer patients and their correlation when breast cancer cells suffer stressful situations.

Authors:  F Darío Cuello-Carrión; Jorge E Shortrede; Daiana Alvarez-Olmedo; Niubys Cayado-Gutiérrez; Gisela N Castro; Felipe C M Zoppino; Martín Guerrero; Estefania Martinis; Rodolfo Wuilloud; Nidia N Gómez; Verónica Biaggio; Javier Orozco; Francisco E Gago; Leonardo A Ciocca; Mariel A Fanelli; Daniel R Ciocca
Journal:  Clin Exp Metastasis       Date:  2015-02-01       Impact factor: 5.150

Review 3.  Protein biomarkers for subtyping breast cancer and implications for future research.

Authors:  Claudius Mueller; Amanda Haymond; Justin B Davis; Alexa Williams; Virginia Espina
Journal:  Expert Rev Proteomics       Date:  2018-01-03       Impact factor: 3.940

4.  Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.

Authors:  Katrine L Henriksen; Birgitte B Rasmussen; Anne E Lykkesfeldt; Susann Møller; Bent Ejlertsen; Henning T Mouridsen
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

5.  Predicting the clinical status of human breast cancer by using gene expression profiles.

Authors:  M West; C Blanchette; H Dressman; E Huang; S Ishida; R Spang; H Zuzan; J A Olson; J R Marks; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

6.  ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors.

Authors:  A A Keshgegian
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

7.  Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes.

Authors:  Mothaffar F Rimawi; Priya B Shetty; Heidi L Weiss; Rachel Schiff; C Kent Osborne; Gary C Chamness; Richard M Elledge
Journal:  Cancer       Date:  2010-03-01       Impact factor: 6.860

8.  Determination of ErbB2 protein in breast cancer tissues by different methods. Relationships with other biological parameters.

Authors:  A Piffanelli; R Dittadi; L Catozzi; M Gion; G Capitanio; M C Gelli; A Brazzale; R Malagutti; D Pelizzola; A Menegon; G Giovannini; G Gardini
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.

Authors:  Hardik Dodiya; Amit Patel; Dipal Patel; Ashish Kaushal; D G Vijay
Journal:  Indian J Clin Biochem       Date:  2013-01-03

10.  HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer.

Authors:  Christian F Singer; Daphne Gschwantler-Kaulich; Anneliese Fink-Retter; Georg Pfeiler; Ingrid Walter; Gernot Hudelist; Samir Helmy; Anne-Catherine Spiess; Wolfgang Lamm; Ernst Kubista
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.